Interview with Michele Garot, Vice President, BeCRO
What was the motivation behind the establishment of BeCRO and why was it only established in 2010 given the strength of Belgium’s clinical trials industry? Philippe van der Hofstadt: Prior…
Address: Sint lambertusstraat 141 Rue Saint LambertB- 1200 Brussels,Belgium
Tel:
Web: http://www.becro.be/
BeCRO is the Belgian Association of CRO’s. BeCRO was initially founded by 19 member companies and has now grown to include 32 active members, representing more than a third of the 83 identified CRO’s in the country in 2011.
The aims of BeCRO are:
– To establish an association of service and consultancy companies active in pharmaceutical and medical development for health products, companies involved in the running of complete preclinical or clinical trials or parts thereof,- To represent and defend the interests of such companies to health authorities, companies, institutions and organisations operating in the health sector,- To be recognised as a privileged interlocutor by health authorities, any professional bodies and any national or international association and/or federation,- To establish good operating practices, with respect as regards highest quality rules and Good Clinical Practices,- To work towards training its members,- To promote the association.
What was the motivation behind the establishment of BeCRO and why was it only established in 2010 given the strength of Belgium’s clinical trials industry? Philippe van der Hofstadt: Prior…
Deloitte is certainly renowned for its strong network of international expertise in the field of life sciences having teams in all of the crucial markets able to cater to their…
Historically, Belgium is widely recognized as a major regional hub for clinical development. How would you compare the current environment to 1999, when Archemin was first established, and how has…
An in-depth viewpoint on the current taxation situation for pharmaceutical companies operating in Belgium today, looking at incentive programs and relative positioning in Europe. Mr Eynatten, can you please…
Deloitte is certainly renowned for its strong network of international expertise in the field of life sciences having teams in all of the crucial markets able to cater to their…
Deloitte is certainly renowned for its strong network of international expertise in the field of life sciences having teams in all of the crucial markets able to cater to their…
Donald Niesten and Omer Saka discuss the current dynamics of the healthcare and pharmaceutical sectors in Belgium, the challenges of entering the market and the issue of effective communication…
This August marks your sixth year at the helm of the Belgian affiliate of Ferring, what would you say best explains your loyalty to the company? One element that appeals…
UCB was founded in 1928 by Mr Emmanuel Janssen in Belgium, what spirit would you say its founder left behind and what core values unique to the company were you…
Since 1969, Eli Lilly & Company has been investing in Belgium. Can you give our readers a brief overview of the company’s history here and highlight some of your most…
The managing director of Brussels Invest & Export discusses Belgium’s unique attractiveness when it comes to the life sciences, and which countries and companies are interested in investing in the…
Could you tell our readers who are not familiar with the Biopark with an introduction of the Biopark and its institutes? The BioPark of Charleroi Brussels South is a campus…
The generics market in Belgium doesn’t seem to be at the level it deserves to be. Considering that Mylan controls about 14% of the local generics market share, how would…
See our Cookie Privacy Policy Here
